30 November 2010
Humidification during high-frequency oscillatory ventilation for adults: A bench study
Yusuke ChikataABCDEF, Hideaki ImanakaABCDEF, Masahiko UetaAFG, Masaji NishimuraABCDEFGMed Sci Monit 2010; 16(12): MT89-93 :: ID: 881280
Abstract
Background: High-frequency oscillatory ventilation (HFOV) has recently been applied to acute respiratory distress syndrome patients. However, the issue of humidification during HFOV has not been investigated. In a bench study, we evaluated humidification during HFOV for adults to test if adequate humidification was achieved in 2 different HFOV systems.
Material/Methods: We tested 2 brands of adult HFOV ventilators, the R100 (Metran, Japan) and the 3100B (SensorMedics, CA), under identical bias flow. A heated humidifier consisting of porous hollow fiber (Hummax II, Metran) was set for the R100, and a passover-type heated humidifier (MR850, Fisher & Paykel) was set for the 3100B, while inspiratory heating wire was applied to both systems. Each ventilator was connected to a lung model in an incubator. Absolute humidity, relative humidity and temperature at the airway opening were measured using a hygrometer under a variety of ventilatory settings: 3 stroke volumes/amplitudes, 3 frequencies, and 2 mean airway pressures.
Results: The R100 ventilator showed higher absolute humidity, higher relative humidity, and lower temperature than the 3100B. In the R100, as stroke volume and frequency increased, absolute humidity and temperature increased. In the 3100B, amplitude, frequency, and mean airway pressure minimally affected absolute humidity and temperature. Relative humidity was almost 100% in the R100, while it was 80.5±2.3% in the 3100B.
Conclusions: Humidification during HFOV for adults was affected by stroke volume and frequency in the R100, but was not in the 3100B. Absolute humidity was above 33 mgH_2 O/L in these 2 systems under a range of settings.
Keywords: Humidity, Respiratory Distress Syndrome, Adult - therapy, High-Frequency Ventilation - methods
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952